Insider Transactions Reported by 14 Insiders of DICE Therapeutics, Inc.

Location
South San Francisco, CA

Sponsored

Quick Takeaways

  • DICE Therapeutics, Inc. has 14 insiders with reported activity on this page.
  • No net insider buy/sell flow is currently reported for the last year.
  • Recent transaction rows are not currently available.

What Changed

  • No meaningful buy/sell imbalance is currently visible in the one-year window.
  • Activity will update as new Forms 3/4/5 are filed.

Why This Matters

  • This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
  • Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.

Official SEC Source

Filed on Form 4

Issuer insider activity is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Insider trading overview

Last 12 months

Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 10 Apr 2025.

Buys

$0

Shares: 0

Insiders: 0

Sells

$0

Shares: 0

Insiders: 0

Net

$0

Shares: 0

Insiders: 0

Window (months) Buy shares Sell shares Buy $ Sell $ Net $
0-3 0 0 $0 $0 $0
3-6 0 0 $0 $0 $0
6-9 0 0 $0 $0 $0
9-12 0 0 $0 $0 $0

DICE Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Valuation Report Date
Northpond Ventures GP, LLC 10%+ Owner $37,200,001 Filing P/S 22 Jun 2023
Lisa Bowers Director Mixed 09 Aug 2023
Richard H. Scheller Director Mixed 09 Aug 2023
James Paul Scopa Director Mixed 09 Aug 2023
Kevin Judice CEO, Director Mixed 09 Aug 2023
Scott M. Robertson Cfo & Cbo Mixed 09 Aug 2023
Jake Simson Director Mixed 09 Aug 2023
Stephen Zachary Director Mixed 14 Sep 2021
Mittie Doyle Director Mixed 09 Aug 2023
Timothy Lu Cmo Mixed 09 Aug 2023
RA CAPITAL MANAGEMENT, L.P. Former 10% owners and Director Mixed 09 Aug 2023
Sharon Tetlow Director Mixed 09 Aug 2023
John R. Jacobsen Cso Mixed 09 Aug 2023
Shaan-Chirag C. Gandhi Director Mixed 14 Sep 2021

Top shareholders of DICE Therapeutics, Inc. (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Northpond Ventures GP, LLC
3/4/5
10%+ Owner —
class O/S missing
800,000
 $37,200,001 — 22 Jun 2023
3/4/5

Recent Insider Transactions by Companies or Individuals for DICE Therapeutics, Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
No insider transactions were found in the last 12 months for this issuer.
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Sponsored